Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
申请人:Wyeth
公开号:US20040102480A1
公开(公告)日:2004-05-27
This invention provides compounds of Formula I having the structure
1
wherein:
A is O, S, or N;
B is —(CH
2
)
m
—, —CH(OH)—, or carbonyl;
R
1
is hydrogen, halogen, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, or trifluoromethyl;
R
2
is alkyl of 1-18 carbon atoms, aryl of 6-10 carbon atoms, arylalkyl of 7-15 carbon atoms, Het-alkyl wherein the alkyl moiety is 1-6 carbon atoms;
Het is
2
R
2a
is alkylene of 1-3 carbon atoms;
G is oxygen, sulfur, or nitrogen;
R
3
, R
4
are each, independently, hydrogen, halogen, alkyl of 1-3 carbon atoms, aryl of 6-10 carbon atoms or a heterocyclic ring of 5 to 7 ring atom containing 1 to 3 heteroatoms selected from oxygen, nitrogen, sulfur;
R
5
is hydrogen, alkyl of 1-6 carbon atoms, —CH(R
7
)R
8
, —C(CH
2
)
n
CO
2
R
9
, —C(CH
3
)
2
CO
2
R
9
, —CH(R
7
)(CH
2
)
n
CO
2
R
9
, or CH(R
7
)C
6
H
4
CO
2
R
9
;
R
6
is hydrogen, halogen, alkyl of 1-6 carbon atoms, or —OR
5
;
m=1-6;
n=1-6;
R
7
is hydrogen, alkyl of 1-6 carbon atoms, aryl of 6-10 carbon atoms, or arylalkyl of 7-15 carbon atoms;
R
8
is —CO
2
R
10
, —CONHR
10
, tetrazole, or —PO
3
;
R
9
and R
10
are each, independently, hydrogen, alkyl of 1-6 carbon atoms, aryl of 6-10 carbon atoms, or arylalkyl of 7-15 carbon atoms;
or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
该发明提供了具有结构式I的化合物,其中:A为O、S或N;B为—(CH2)m—、—CH(OH)—或羰基;R1为氢、卤素、1-6个碳原子的烷基、1-6个碳原子的烷氧基或三氟甲基;R2为1-18个碳原子的烷基、6-10个碳原子的芳基、7-15个碳原子的芳基烷基、Het-alkyl,其中烷基部分为1-6个碳原子;Het为2R2a为1-3个碳原子的烷基;G为氧、硫或氮;R3、R4分别独立地为氢、卤素、1-3个碳原子的烷基、6-10个碳原子的芳基或含有1-3个杂原子(选自氧、氮、硫)的5至7个环原子的杂环;R5为氢、1-6个碳原子的烷基、—CH(R7)R8、—C(CH2)nCO2R9、—C(CH3)2CO2R9、—CH(R7)(CH2)nCO2R9或CH(R7)C6H4CO2R9;R6为氢、卤素、1-6个碳原子的烷基或—OR5;m=1-6;n=1-6;R7为氢、1-6个碳原子的烷基、6-10个碳原子的芳基或7-15个碳原子的芳基烷基;R8为—CO2R10、—CONHR10、四唑或—PO3;R9和R10各自独立地为氢、1-6个碳原子的烷基、6-10个碳原子的芳基或7-15个碳原子的芳基烷基;或其药学上可接受的盐,用于治疗与胰岛素抵抗或高血糖有关的代谢障碍。